Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ALEMBIC 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ALEMBIC 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Alembic Pharmaceuticals Europe Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 04a358e5245f2c04
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ALEMBIC 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85886
Holder Company Name: Alembic Pharmaceuticals Europe Limited
Marketing Company Name: Alembic Pharmaceuticals Europe Limited
Authorization Date: 2021-03-31
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg/5 mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Alembic Pharmaceuticals Europe Limited

OLMESARTAN MEDOXOMILO

20 mg

AMLODIPINO BESILATO

6,95 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 31, 2021

Approval ID

04a358e5245f2c04

Type

Standard